Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>Indolent>R*** > TREAT.: > Co: IL. T. Brand Bendamustine

---

Co: IL. T. Brand Bendamustine's subsections
(*) EU Approval Date: 2010.
(*) JP Approval Date: 2010. 10.
(*) JP Launch Date: 2010. 12.
(*) USA Approval Date: 2008. 11.03.
Company
Company Licensee JP:
Mechanism: Alkylating Agent
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2016. 09.27
TradeMark (EU)
TradeMark (JP)
TradeMark (JP) Web-Site
TradeMark (USA)
TradeMark (USA) Web-Site

Co: IL. T. Brand Bendamustine's products
This section has no products